These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31219653)

  • 1. CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond.
    Ahmadzadeh V; Farajnia S; Baghban R; Rahbarnia L; Zarredar H
    J Cell Biochem; 2019 Oct; 120(10):16379-16392. PubMed ID: 31219653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
    Liu C; Zhang L; Liu H; Cheng K
    J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Assisted Seamless Genome Editing in Lactobacillus plantarum and Its Application in
    Zhou D; Jiang Z; Pang Q; Zhu Y; Wang Q; Qi Q
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444197
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR base editors: genome editing without double-stranded breaks.
    Eid A; Alshareef S; Mahfouz MM
    Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the application of CRISPR: From gene to base editing.
    Wu W; Yang Y; Lei H
    Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
    Guitart JR; Johnson JL; Chien WW
    J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing.
    Liu Y; Tao W; Wen S; Li Z; Yang A; Deng Z; Sun Y
    mBio; 2015 Nov; 6(6):e01714-15. PubMed ID: 26556277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.